Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Alzhemed add-on therapy study in mild to moderate Alzheimer's disease
2004-003435-31Phase 3Completed
- Sponsor
- Neurochem Inc.
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tramiprosate in Alzheimer's disease (AD) (2 arms), sponsored by Neurochem Inc. Primary endpoints: Change from baseline to Week 78 in ADAS-cog, Change from baseline to Week 78 in CDR-SB and 1 more. Started Jun 2005; status: completed.
02
Drugs
tramiprosate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2004-003435-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003435-31.